Type 2 Diabetes Remission in Patients with Heterozygous Variants in the Leptin-Melanocortin Pathway after Roux-en-Y Gastric Bypass: A Matched Case–Control …

D Anazco, W Ghusn, A Campos, L Cifuentes, S Fansa… - Obesity Surgery, 2023 - Springer
Background Roux-en-Y gastric bypass (RYGB) is associated with a high rate of type 2
diabetes (T2D) remission. Carriers of heterozygous variants in the leptin-melanocortin …
被引用次数：2 相关文章

Type 2 Diabetes Remission in Patients with Heterozygous Variants in the Leptin-Melanocortin Pathway after Roux-en-Y Gastric Bypass: A Matched Case-Control …

D Anazco, W Ghusn, A Campos… - Obesity …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Roux-en-Y gastric bypass (RYGB) is associated with a high rate of type 2
diabetes (T2D) remission. Carriers of heterozygous variants in the leptin-melanocortin …

Type 2 Diabetes Remission in Patients with Heterozygous Variants in the Leptin-Melanocortin Pathway after Roux-en-Y Gastric Bypass: A Matched Case–Control …

D Anazco, W Ghusn, A Campos… - Obesity …, 2023 - mayoclinic.elsevierpure.com
Background: Roux-en-Y gastric bypass (RYGB) is associated with a high rate of type 2
diabetes (T2D) remission. Carriers of heterozygous variants in the leptin-melanocortin …

Type 2 Diabetes Remission in Patients with Heterozygous Variants in the Leptin-Melanocortin Pathway after Roux-en-Y Gastric Bypass: A Matched Case-Control …

D Anazco, W Ghusn, A Campos, L Cifuentes… - Obesity …, 2023 - europepmc.org
Background Roux-en-Y gastric bypass (RYGB) is associated with a high rate of type 2
diabetes (T2D) remission. Carriers of heterozygous variants in the leptin-melanocortin …